Results 171 to 180 of about 287,679 (291)

Paclitaxel-Fe3O4 nanoparticles inhibit growth of CD138–  CD34– tumor stem-like cells in multiple myeloma-bearing mice

open access: gold, 2013
Jun Dou   +8 more
openalex   +2 more sources

Contemporary and Emerging Therapies in the Management of Refractory Angina: A Clinical Review

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Refractory angina (RA) represents a growing challenge in clinical cardiology, particularly in patients with obstructive coronary artery disease (CAD) who remain symptomatic despite optimal medical therapy and who are not candidates for revascularization.
Alex Angers‐Goulet   +4 more
wiley   +1 more source

Phase 1 Clinical Study of Mgta-145 in Combination with Plerixafor Shows Rapid Single-Day Mobilization and Collection of CD34+ HSCs without G-CSF

open access: hybrid, 2020
John F. DiPersio   +14 more
openalex   +1 more source

Analysis of Patients With Monocytic and Monocytic‐Like Acute Myeloid Leukemia, Including AML‐M4 and AML‐M5, Treated With Venetoclax Plus Azacitidine

open access: yes
American Journal of Hematology, EarlyView.
Marina Konopleva   +8 more
wiley   +1 more source

Prospective validation of podoplanin expression as a diagnostic biomarker of acute promyelocytic leukemia

open access: yesCytometry Part B: Clinical Cytometry, EarlyView.
Abstract Acute promyelocytic leukemia (APL) is a medical emergency that needs immediate diagnosis and treatment. Podoplanin, a transmembrane glycoprotein that binds CLEC‐2 on platelets, was recently demonstrated to be abnormally expressed in leukemic blasts in APL, as opposed to other forms of AML, in a study using thawed primary cells.
Camilla Maria de Alencar Saraiva   +7 more
wiley   +1 more source

Cell State Transitions Drive the Evolution of Disease Progression in B-Lymphoblastic Leukemia. [PDF]

open access: yesCancer Res Commun
Gravenmier C   +7 more
europepmc   +1 more source

Investigating the extremes of the continuum of paracrine functions in CD34/CD31+ CACs across diverse populations [PDF]

open access: bronze, 2016
Rian Q. Landers‐Ramos   +9 more
openalex   +1 more source

Baseline Factors Identified For Prediction of Good Responders in Patients With End-Stage Diffuse Coronary Artery Disease Undergoing Intracoronary CD34+ Cell Therapy [PDF]

open access: gold, 2020
Pei‐Hsun Sung   +8 more
openalex   +1 more source

Basiliximab in the Prophylaxis of aGVHD for Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients With Thalassemia Major: A Prospective, Multicenter, Open‐Label, Randomized Controlled Study

open access: yes
American Journal of Hematology, EarlyView.
Zhenbin Wei   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy